Integer Holdings Executive and Leadership Team

Payman Khales, the President & Chief Executive Officer at Integer Holdings, directs the overarching corporate strategy for the global medical device outsource manufacturing sector. Khales architects long-term growth plans while overseeing the integration of Greatbatch Medical, Lake Region Medical, and Electrochem brands into a unified market force. By aligning internal manufacturing capabilities with the evolving needs of cardiac, neuromodulation, and vascular OEMs, the President & Chief Executive Officer ensures consistent delivery of high-quality technologies. Payman Khales maintains direct oversight of executive leadership teams to foster a culture of innovation and integrity. This leadership role involves navigating complex regulatory environments and expanding the company footprint across international markets. Through rigorous focus on operational excellence and customer-centric solutions, the President & Chief Executive Officer drives the organization toward sustained profitability and industry-leading performance in the competitive medical device landscape.

Steven Schaepe, the Chief Financial Officer & Executive VP, Corporate Development at Integer Holdings, manages the financial health and strategic expansion efforts of the organization. Schaepe oversees capital allocation, financial reporting, and investor relations to ensure alignment with the broader corporate mission of supporting medical device OEMs. By evaluating potential acquisitions and partnerships, the Chief Financial Officer & Executive VP, Corporate Development identifies opportunities to strengthen the portfolio within the cardiac and vascular markets. Steven Schaepe directs the financial planning processes that support large-scale manufacturing investments and research initiatives. This role requires constant collaboration with the executive team to balance fiscal discipline with aggressive growth targets. Through meticulous analysis of market trends and internal performance metrics, the Chief Financial Officer & Executive VP, Corporate Development secures the necessary resources to maintain the company status as a premier provider of innovative medical technologies and niche energy applications.

Diron Smith, the Executive VP & Chief Financial Officer at Integer Holdings, leads the financial strategy and fiscal governance for the enterprise. Smith oversees the accounting, treasury, and tax functions, ensuring robust financial controls across all business units. By providing data-driven insights into cost structures and revenue streams, the Executive VP & Chief Financial Officer enables informed decision-making regarding manufacturing investments and market expansion. Diron Smith manages the financial reporting cycle to maintain transparency with shareholders and regulatory bodies. This role involves working closely with the Board to assess risk and optimize the balance sheet for long-term stability. Through the implementation of advanced financial systems, the Executive VP & Chief Financial Officer supports the company mission of delivering innovative solutions to the medical and energy sectors. Smith ensures that financial resources remain aligned with the strategic goals of the organization while fostering a culture of fiscal accountability.

Jeremy Friedman, the Executive Vice President & Chief Operating Officer at Integer Holdings, governs the global manufacturing operations and supply chain logistics for the company. Friedman architects scalable production processes that support the cardiac, neuromodulation, and portable medical markets. By optimizing facility performance and implementing lean manufacturing principles, the Executive Vice President & Chief Operating Officer ensures that high-quality components reach medical device OEMs with maximum efficiency. Jeremy Friedman monitors operational workflows across all production sites to maintain strict adherence to quality standards and safety protocols. This leadership role involves coordinating with engineering teams to translate complex designs into reliable, life-enhancing products. Through the continuous improvement of manufacturing infrastructure, the Executive Vice President & Chief Operating Officer drives operational excellence and supports the company commitment to providing unparalleled expertise to customers worldwide while managing the complexities of a global supply chain.

Andrew Senn, the President, Growth & Innovation at Integer Holdings, spearheads the research and development pipeline to advance the company technological capabilities. Senn architects the strategy for new product development, focusing on high-end niche applications in the medical, military, and environmental markets. By identifying emerging trends in medical device technology, the President, Growth & Innovation ensures that the company remains at the forefront of industry-changing innovations. Andrew Senn collaborates with engineering and marketing teams to bring cutting-edge solutions from concept to commercialization. This leadership role involves managing the innovation portfolio to drive sustainable revenue growth and market differentiation. Through the cultivation of strategic partnerships and the exploration of new manufacturing methodologies, the President, Growth & Innovation enhances the value proposition for global OEMs. Senn maintains a relentless focus on delivering technological excellence that directly improves patient outcomes and supports the long-term vision of the organization.